About Moray Wright

Moray is Chief Operating Officer of Parkwalk, which he co-founded in 2009.

20 September 2016

Horizon Discovery – Strong Revenue Growth and Focus on Operational Gearing Underpin Path to Profitability

By |September 20th, 2016|

Cambridge, UK, 20 September 2016: Horizon Discovery Group plc (LSE: HZD), a world leader in the application of gene editing technologies, announces its interim results for the six months ended 30 June 2016.
Highlights (including post period end):
·     Group revenue increased 19% to £10.2 million (HY15: £8.6 million)
·     Products business revenue increased 62% to £4.8 […]

Revolymer – Divestment of nicotine gum business

By |September 19th, 2016|

Further to the announcement published on 20 June 2016, Revolymer (AIM: REVO) announces that, on 16 September 2016, it executed agreements committing it to divest its nicotine gum business to the Danish company Alkalon A/S (“Alkalon”), with completion subject only to the satisfaction of certain customary conditions precedent including the transfer of key customer […]

OxfordPV – Parkwalk closes further funding round

By |September 16th, 2016|

We are pleased to announce that Parkwalk has made a further investment in OxfordPV through a the Opportunities EIS Fund.

Oxford Photovoltaics is an Oxford-based technology business, founded in 2010, formed on technology originally developed in the Department of Physics at the University of Oxford under Professor Henry Snaith and his academic team of 20 scientists.

Professor Snaith is […]

Microsaic Systems – Parkwalk Opportunities Fund closes follow on investment

By |September 12th, 2016|

We are delighted to have participated in a placing for Microsaic Systems:
12 September 2016
On 26 August 2016, Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announced a proposed Placing to raise up to £5.4 million (before expenses) through the issue of up to 108,000,000 new ordinary shares of 0.25p each (“New Ordinary Shares”) […]

Arvia Technologies – WEFTEC Innovative Technology Award

By |September 1st, 2016|

Arvia Technology will receive the prestigious Innovative Technology Award from the Water Environment Federation (WEF), an international not-for-profit technical and educational water quality organisation. The award will be presented during a ceremony at WEFTEC 2016, the organisation’s 89th Annual Technical Exhibition and Conference this fall in New Orleans, La.

The Innovative Technology Award recognises Arvia’s […]

Healthera – University of Cambridge Enterprise Fund III investment

By |September 1st, 2016|

We are delighted to announce that the University of Cambridge Enterprise Fund III has invested in Healthera Ltd, a provider of next-generation, pharmacy-integrated personal health management solutions, has secured seed investment from the University of Cambridge, the University of Cambridge Enterprise Fund III, FT Capital and high net worth individuals. The specific amounts are undisclosed.

This […]

31 August 2016

Brainomix – Parkwalk closes follow-on investment

By |August 31st, 2016|

We have recently closed an investment in Brainomix for the Parkwalk UK Tech Fund VII and the Opportunities Fund.

Brainomix is aiming to improve stroke treatment dramatically by developing software that gives all hospitals and clinics access to reliable diagnoses for their patients.

Brainomix’s ground-breaking technology, e-ASPECTS is a clinical decision support tool that automatically implements the Alberta […]

Animal Dynamics – MoD Skeeter Press Release

By |August 15th, 2016|

Animal Dynamics’ Skeeter Unmanned Aerial System highlighted in new initiative announced by the MoD:

View the MoD Website here, Sky news here, FT (paywall) here and the Times (paywall) here.


PervasID – University of Cambridge Enterprise Fund IV investment

By |August 10th, 2016|

We are delighted to announce that the University of Cambridge Enterprise Fund IV, managed by Parkwalk, has invested in PervasID, a spin-out from the Department of Engineering.

The company has developed a long-range passive Radio-Frequency Identification (RFID) tracking technology which substantially outperforms current passive RFID technologies. Crucially, it allows low-cost commodity RFID tags to be […]

Micrima – University of Bristol Enterprise Fund I investment

By |August 10th, 2016|

We are delighted to announce that the University of Bristol Enterprise Fund I, managed by Parkwalk, has invested in Micrima.

The company intends to develop and commercialise a new Breast Imaging System (MARIA) aimed at radically improving breast cancer detection and survival rates through the provision of much safer, more frequent, more comfortable and less expensive […]

Salunda – Parkwalk follow-on Investment

By |August 5th, 2016|

We have recently closed an investment in Salunda for the Parkwalk Opportunities Fund.

Salunda develops robust, contactless sensors for use in very harsh environments. The company’s sensor technology detects position and speed, and measures the composition of fluids.

Salunda has developed patented, contactless sensor technology for monitoring machinery in very harsh environments. Sensors scan components such […]

26 July 2016

YASA Motors – P400 Series with Lightweight Gearbox

By |July 26th, 2016|


Integrated Lightweight Electric Vehicle Transmissions
Application example:
YASA P400 Series Motors with lightweight gearboxes.
Xtrac, a leader in the design and manufacture of vehicle transmissions, has a family of highly configurable gearboxes available that address the growing market requirement for single speed, lightweight and power dense electric vehicle (EV) transmissions. Driven by YASA P400 Series motors, the Xtrac P1227 Integrated […]

Fluidic Analytics – University of Cambridge Enterprise Fund IV and Parkwalk investment

By |July 25th, 2016|

Parkwalk have recently closed an investment in Fluidic Analytics for the University of Cambridge Enterprise Fund IV and Parkwalk Funds.

Fluidic Analytics is developing a line of tools for the rapid, accurate, cost-effective analysis of proteins and other biomolecular species. By combining a powerful microfluidics platform developed at the University of Cambridge with efficient manufacturing and design principles, […]

ARM Holdings – £24.3bn acquisition of the University of Cambridge spin-out

By |July 18th, 2016|

Japan’s Softbank on Monday offered £24.3bn ($32bn) in cash to acquire 100% of ARM Holdings, the UK’s smartphone chip designer that is one of the leaders in the infrastructure of the internet of things.

In 2015, Forbes ranked ARM as the most innovative company in Europe, and the fifth most innovative in the world.

The deal […]

PsyOmics – University of Cambridge Enterprise Fund IV investment

By |July 7th, 2016|

We are delighted to announce that the University of Cambridge Enterprise Fund IV, managed by Parkwalk, has invested in PsyOmics, a spin-out from the Department of Chemical Engineering and Biotechnology.

The company aims to utilise blood-based diagnostics to increase the speed of diagnosis and to reduce misdiagnosis for mental health patients.

Mental illness accounts for over […]

8Power – University of Cambridge Enterprise Fund III investment

By |July 4th, 2016|

We have recently made an investment in 8Power for the University of Cambridge Enterprise Fund III in a financing round.

8power Limited, a new company spun out of the University of Cambridge to develop and commercialise novel technology for sensing and measurement in industrial applications, has received initial funding of approximately £700,000 from IP Group plc […]

29 June 2016

Oxford University Innovation – the new name for Isis Innovation

By |June 29th, 2016|

Isis Innovation will be renamed Oxford University Innovation, in order to enhance the already strong links between Isis Innovation and the University. This will strengthen awareness of the company and its services within the wider University, and better portray the University’s ownership of the company.
With a record 16 spinout companies launched and more than […]

Parkwalk, the EIS and Brexit

By |June 28th, 2016|

In these uncertain times post the surprise vote to leave the EU, investors are (quite rightly) focusing on macro risks and volatility.
However, as the dust begins to settle they are now looking across the fringes of their portfolios, including alternative assets such as VC and PE. As a small part of that portfolio with […]

Revolymer – acquisition and sale of nicotine gum business

By |June 21st, 2016|

Revolymer PLC, the AIM-listed specialty chemicals company, on Monday said it agreed to buy Itaconix Corp, a privately owned polymer company based in New Hampshire, for up to USD13.0 million in cash and shares, in an acquisition to be supported by a share placing to raise GBP4.0 million, and to sell its nicotine gum […]

Parkwalk portfolio company CCMOSS – acquired by ams AG to become world leader in gas and infrared sensing

By |June 16th, 2016|

ams AG (SIX: AMS), a leading worldwide manufacturer of high performance sensor and analog solutions, has acquired 100% of the shares in Cambridge CMOS Sensors Ltd (CCS), the technology leader in micro hotplate structures for gas sensing and infrared applications, in an all-cash transaction.
Founded in 2008 as a spin-off from Cambridge University, with the […]